This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jens S Anderson: Innovator in Therapeutic Antibody Applications
Introduction
Jens S Anderson is a notable inventor based in Odense SO, Denmark. He has made significant contributions to the field of therapeutic applications of antibodies, particularly in relation to nervous tissue and cardiovascular disorders. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Jens S Anderson holds a patent for the therapeutic use of antibodies directed against repulsive guidance molecule (RGM). This invention relates to the use of a modulator of a polypeptide for the preparation of pharmaceutical compositions aimed at preventing, alleviating, or treating diseases associated with the degeneration or injury of vertebrate nervous tissue. The patent also covers conditions related to seizures, angiogenic disorders, and cardiovascular system disorders. Furthermore, it provides methods for using the polypeptide or its derivatives in treating tumor growth and as a marker for stem cells.
Career Highlights
Anderson is affiliated with the Max Planck Society for the Advancement of Science, where he continues to engage in groundbreaking research. His work has been instrumental in advancing the understanding of therapeutic applications in medicine. With a focus on innovative solutions, he has contributed to the scientific community through his research and patent.
Collaborations
Jens S Anderson has collaborated with esteemed colleagues such as Bernhard K Mueller and Philippe Patrick Monnier. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their respective fields.
Conclusion
Jens S Anderson's contributions to the field of therapeutic antibodies highlight his role as a significant inventor. His patent work demonstrates a commitment to addressing critical health challenges through innovative solutions. His ongoing research and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile